Hemolysis and jaundice in the newborn following maternal treatment with sulfamethoxypyridazine (kynex).
D001741:Black or African American; D004899:Erythroblastosis, Fetal / Q000209:etiology*; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000209:etiology*; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology*; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D013421:Sulfamethoxypyridazine / Q000009:adverse effects*
D013421:Sulfamethoxypyridazine